This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 4 – 10 December 2022 and includes updates on COVID-19, Ebola virus, respiratory syncytial virus, streptococcal infection, diphtheria, seasonal influenza, mpox (monkeypox), hepatitis, MERS-CoV, meningitis, and mass gathering monitoring at the FIFA World Cup 2022 Qatar.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 October 2022 and includes updates on avian influenza, COVID-19, dengue, Ebola, invasive meningococcal disease, West Nile Virus, MERS-CoV, monkeypox, and hepatitis.
For 2020, 28 EU/EEA countries reported 4 824 confirmed cases of Shiga toxin -producing Escherichia coli (STEC) infection. The overall notification rate was 1.6 cases per 100 000 population. The highest notification rates were reported in Ireland, Malta, Denmark, and Norway. The EU/EEA notification rate decreased notably in 2020 compared with 2016-2019 due to the COVID-19 pandemic.
In 2018, 3 233 confirmed cases of invasive meningococcal disease (IMD), including 324 deaths, were reported in 30 European Union/European Economic Area (EU/EEA) Member States.
This report presents the results of the ECDC European Reference Laboratory Network for Pertussis (ERLNPert-Net) external quality assessment (EQA) scheme for Bordetella pertussis PCR, funded by ECDC on behalf of ERLNPert-Net and conducted from April to September 2020. The EQA was organised by the National Institute for Biological Standards and Control (NIBSC), based in Potter’s Bar, United Kingdom (UK).
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 2-8 January 2022 and includes updates on COVID-19, the Omicron variant, avian influenza, seasonal influenza, MERS-CoV, meningitis, dengue and chikungunya.
This report presents the results of the 10th round of the external quality assessment (EQA-10) scheme for typing of Shiga toxin-producing Escherichia coli (STEC).